血管外科

Medicine and Dentistry

1. Patient 100%
2. Inpatient 36%
3. Endovascular Aneurysm Repair 36%
4. Combination Therapy 35%
5. Abdominal Aortic Aneurysm 32%
6. Aneurysm 30%
7. Arteriovenous Fistula 26%
8. Surgery 26%
9. Revascularization 25%
10. Limb 25%
11. Critical Limb Ischemia 24%
12. Sarcopenia 24%
13. Benzimidazole 24%
14. Therapeutic Procedure 21%
15. Neck 18%
16. Cardiovascular System 17%
17. Overall Survival 17%
18. Bypass 17%
19. Fistula 16%
20. Survival Rate 15%
21. Maturation 14%
22. Vein Graft 14%
23. Nutritional Status 14%
24. Iliac Artery Aneurysm 14%
25. Amputation 14%
26. Stent 14%
27. Computer Assisted Tomography 13%
28. Cells 12%
29. Smooth Muscle Cell 11%
30. Age 11%
31. Endoleak 11%
32. Frailty 11%
33. Abdominal Aortic Aneurysm Repair 11%
34. Arteriosclerosis Obliterans 10%
35. Macrophage 10%
36. Survival 10%
37. Lung Cancer 10%
38. Artery Graft 10%
39. Ischemia 10%
40. Hazard Ratio 10%
41. Skeletal Muscle 10%
42. Artery 10%
43. Incidence 9%
44. T Cell 9%
45. Anatomy 9%
46. Cell Proliferation 9%
47. Artery Intima Proliferation 9%
48. Follow up 8%
49. Prognostic Factor 8%
50. Aorta 8%
51. Stenosis 8%
52. Multivariate Analysis 8%
53. Knee 8%
54. Examination 7%
55. Prognosis 7%
56. Aortic Smooth Muscle Cell 7%
57. Femoral Artery 7%
58. Antiplatelet 7%
59. Wound Healing 7%
60. Intimal Hyperplasia 7%
61. Death 7%
62. Malignant Neoplasm 7%
63. Woman 6%
64. Serositis 6%
65. Intermittent Claudication 6%
66. Female 6%
67. Common Iliac Artery 6%
68. Arterial Embolization 6%
69. Predictor 6%
70. Analysis 6%
71. Malnutrition 6%
72. Ulcer Healing 6%
73. Injury 6%
74. Neoplasm 6%
75. Limb Salvage 5%
76. Regulatory Mechanism 5%
77. Vascular Smooth Muscle Cell 5%
78. Angiotensin II 5%
79. Fibrinogen 5%
80. Man 5%
81. Internal Iliac Artery 5%
82. Tissues 5%
83. Sex Difference 5%
84. Hemodialysis 5%
85. Complication 5%
86. Cancer 5%
87. Geriatrics 5%
88. Hybrid 5%
89. Superior Mesenteric Artery 5%
90. Lesion 5%
91. Stent-Graft 5%
92. Hospital 5%
93. Postoperative Complication 5%
94. Solitary Fibrous Tumor 5%
95. Thigh 5%
96. Programmed Death 1 Ligand 1 5%
97. Trunk 5%
98. Apolipoprotein E 5%
99. Induced Pluripotent Stem Cell 5%
100. Blood Autotransfusion 5%